T2 -Based MRI Delta-Radiomics Improve Response Prediction in Soft-Tissue Sarcomas Treated by Neoadjuvant Chemotherapy.

Journal of Magnetic Resonance Imaging - United States
doi 10.1002/jmri.26589
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Tumor Grading of Soft Tissue Sarcomas Using MRI-based Radiomics

EBioMedicine
BiochemistryMedicineGeneticsMolecular Biology
2019English

Neoadjuvant Chemotherapy in Soft Tissue Sarcomas: Latest Evidence and Clinical Implications

Therapeutic Advances in Medical Oncology
Oncology
2017English

Chemotherapy in Pediatric-Type Soft-Tissue Sarcomas

Current Oncology
Oncology
2020English

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Frontiers in Oncology
Cancer ResearchOncology
2019English

Feasibility of Chemotherapy in Treatment of Adult Soft Tissue Sarcomas

Orthopedics & Traumatology
2005English

Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer

Journal of Medical – Clinical Research & Reviews
2019English

Head and Neck Soft Tissue Sarcomas Treated With Radiation Therapy

Rare Tumors
OncologyHistology
2016English

FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses After the Initial Cycle of Neoadjuvant Chemotherapy in High-Grade Soft-Tissue Sarcomas

Clinical Cancer Research
Cancer ResearchOncology
2009English

Notch Signaling in Pediatric Soft Tissue Sarcomas

BMC Medicine
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy